Earth Science Tech (ETST) AI Stock Analysis

• Market Cap: $54.42M
• Dividend Yield: N/A
• Average Volume (3M): 48.76K
• Price to Earnings (P/E): 18.8
• Beta (1Y): 1.63
• Revenue Growth: 64.06%
• EPS Growth: 37.50%
• Country: US
• Employees: 32
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 294,297,600
• 10 Day Avg. Volume: 21,604
• 30 Day Avg. Volume: 48,760
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.01
• Enterprise Value/Revenue: 1.80
• Enterprise Value/Gross Profit: 2.97
• Enterprise Value/Ebitda: 15.98
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 61 Neutral
• Price Target: $0.00 ▼(-100.00% Downside)

Earth Science Tech's overall stock score is driven by its substantial financial recovery and positive technical indicators. While the stock shows promising growth and stability, the valuation is moderate, and the lack of a dividend yield may deter some investors. The absence of earnings call and corporate events data limits further insights.

Earth Science Tech Business Overview & Revenue Model

Company Description

Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. Its products include hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs through its retail store, clinics, pharmacies, as well as through online. It also provides medical equipment and devices. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. The company was incorporated in 2010 and is headquartered in Doral, Florida.

How the Company Makes Money

Earth Science Tech generates revenue through multiple channels, primarily by selling its CBD products directly to consumers and through wholesale distribution to retailers. The company has established a robust online presence, allowing for direct-to-consumer sales via its e-commerce platform. Additionally, ETST benefits from partnerships with various health and wellness businesses that incorporate its products into their offerings, expanding its market reach. Key revenue streams include product sales, online retail, and potential licensing agreements that may arise from its research and development efforts in the hemp industry.

Earth Science Tech Financial Statement Overview

Summary

Earth Science Tech has demonstrated substantial financial recovery and growth, particularly in revenue and cash flow metrics. While past financial instability and high leverage are concerns, recent improvements in profitability and equity position indicate a more stable future outlook.

Income Statement

Earth Science Tech has shown impressive revenue growth, with a significant increase from $140,902 in 2021 to $33,117,624 in 2025. The gross profit margin has also improved, indicating better cost management. However, the net profit margin has been volatile due to fluctuating net income, impacting overall profitability stability.

Balance Sheet

The company's debt-to-equity ratio has improved with a positive equity position as of 2025, contrasting with negative equity in earlier years. However, the relatively high total debt and liabilities still pose a financial stability risk. The return on equity has been erratic due to previous negative equity.

Cash Flow

Earth Science Tech's cash flow situation is strengthening, with significant growth in operating cash flow and positive free cash flow in recent years. The free cash flow to net income ratio suggests efficient cash generation from profits. However, earlier periods showed negative cash flows, indicating past challenges.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	33.12M	11.95M	48.54K	14.12K	140.90K
Gross Profit	24.30M	7.83M	22.06K	-8.52K	39.93K
EBITDA	3.54M	1.04M	-300.48K	-224.28K	-4.30M
Net Income	3.25M	812.14K	144.58K	6.66M	-4.47M
Balance Sheet
Total Assets	7.07M	3.88M	2.69M	76.94K	64.56K
Cash, Cash Equivalents and Short-Term Investments	2.12M	697.72K	35.76K	26.94K	16.16K
Total Debt	401.24K	246.59K	974.11K	682.45K	650.44K
Total Liabilities	3.22M	1.63M	1.61M	1.88M	5.09M
Stockholders Equity	3.85M	2.25M	1.08M	-1.81M	-5.03M
Cash Flow
Free Cash Flow	3.62M	1.18M	-1.01M	-166.39K	-196.69K
Operating Cash Flow	4.37M	1.21M	-1.01M	-168.11K	-196.69K
Investing Cash Flow	-1.88M	-26.52K	0.00	1.71K	0.00
Financing Cash Flow	-1.72M	-517.88K	1.02M	173.18K	182.12K

Earth Science Tech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.16
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.16 is below the 20-day moving average (MA) of 0.19, below the 50-day MA of 0.19, and below the 200-day MA of 0.16, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.68 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.

Earth Science Tech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ETST	61 Neutral	$54.42M	18.75	71.39%	―	64.06%	37.50%
RMTI	52 Neutral	$43.73M	-17.99	-6.90%	―	-6.79%	61.56%
CPHI	46 Neutral	$6.39M	-1.29	-61.13%	―	-29.64%	73.63%
IXHL	39 Underperform	$48.63M	-0.34	―	―	616.67%	-22.13%
KALA	31 Underperform	$14.36M	-0.23	―	―	―	51.27%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Earth Science Tech Corporate Events

Earth Science Tech Reduces Authorized Shares by 50 Million

On August 19, 2025, Earth Science Tech, Inc. announced that its Board of Directors approved a reduction in the company’s authorized shares of common stock from 350 million to 300 million. This decision reflects the board’s confidence in the company’s financial health and strategic plan, aiming to prevent unnecessary shareholder dilution and protect long-term shareholder value.

Earth Science Tech Reports 61% Asset Growth in Q1 2025

On August 8, 2025, Earth Science Tech, Inc. reported a 61% growth in total assets to $7.69 million and revenue of $8.7 million for the first quarter ending June 30, 2025. This growth follows a foundational quarter of strategic acquisitions, including healthcare and direct-to-consumer brands, and marks a shift from acquisitions to enhancing the value and profitability of existing divisions. The company also reduced its outstanding shares by 4.78% and continued to expand its operational infrastructure, including a new customer service center and real estate development projects.

Earth Science Tech Joins OTCID Tier for Growth

On July 1, 2025, Earth Science Tech, Inc. announced its qualification for and listing on the newly launched OTCID tier of the OTC Markets, reflecting its commitment to enhanced disclosure, transparency, and compliance standards. This achievement is expected to boost investor confidence, attract new stakeholders, and support the company’s strategic growth initiatives, marking a significant turnaround for the company over the past two years.

Earth Science Tech Reports Strong Fiscal Year Results

Earth Science Tech, Inc. reported its financial results for the fiscal year ending March 31, 2025, showcasing significant growth with revenue exceeding $33.1 million and a net profit of $3.2 million. The company achieved a 177.05% increase in revenue and a 300.63% rise in net profit compared to the previous year. The results reflect a strong year-over-year improvement in cash, total assets, and gross profit, indicating robust operational performance and strategic growth. Additionally, the company reduced its outstanding shares by 4.72%, enhancing shareholder value.